Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$30.32 - $91.33 $240,225 - $723,607
-7,923 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $683,437 - $942,837
7,923 New
7,923 $739,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Revelation Capital Management, LLC Portfolio

Follow Revelation Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Revelation Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Revelation Capital Management, LLC with notifications on news.